{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:36:11Z","timestamp":1771850171203,"version":"3.50.1"},"reference-count":41,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T00:00:00Z","timestamp":1202342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Multiple myeloma (MM) is the most common indication for high\u2010dose chemotherapy with autologous stem cell transplantation (ASCT) in the U.S. and can be associated with substantial morbidity. Thorough assessment and understanding of symptoms and risk factors for symptom development after ASCT are logical first steps toward developing strategies aimed at reducing the symptom burden associated with this procedure.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The authors performed a prospective evaluation of symptom burden among 64 patients with myeloma who underwent ASCT. Symptom data were collected using the M. D. Anderson Symptom Inventory (MDASI) at 4 time points: baseline, the day of stem cell infusion (Day 0), nadir of counts, and Day 30. Univariate analysis was performed to correlate pretransplantation variables with post\u2010transplantation symptom burden at these time points.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>MDASI scores increased significantly throughout transplantation, with most patients returning to baseline by Day 30 after the procedure. Patients with the highest MDASI scores at baseline had the highest MDASI scores at nadir (<jats:italic>P<\/jats:italic> = .02). Patients with prolonged time to transplantation and women had a trend toward higher nadir global symptom severity scores. These groups, as well as patients aged &gt;60 years, had a trend toward higher nadir interference scores.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>ASCT for MM was associated with significant but reversible symptom burden during the first 30 days, and the baseline symptom burden was the most important predictor of symptom burden after transplantation. The MDASI was useful as a tool for following the symptom burden associated with ASCT and may be used to evaluate interventions aimed at reducing transplantation\u2010related morbidity in these patients. Cancer 2008. \u00a92008 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.23299","type":"journal-article","created":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T11:49:06Z","timestamp":1202384946000},"page":"1617-1624","source":"Crossref","is-referenced-by-count":40,"title":["Symptom burden after autologous stem cell transplantation for multiple myeloma"],"prefix":"10.1002","volume":"112","author":[{"given":"Erica","family":"Campagnaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Roden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floralyn","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Cleeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen O.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,19]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15736-X"},{"key":"e_1_2_5_3_2","first-page":"7","article-title":"Impact on survival of high\u2010dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population\u2010based study. Nordic Myeloma Study Group","volume":"95","author":"Lenhoff S","year":"2000","journal-title":"Blood."},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032290"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2005.n.045"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704465"},{"key":"e_1_2_5_8_2","first-page":"181","article-title":"Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea","volume":"4","author":"Chapko MK","year":"1989","journal-title":"Bone Marrow Transplant."},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200322"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(00)70044-9"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.0551"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000173272.71949.a1"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.7.1539"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.706"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.189"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700921"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.1.242"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.674"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.3.825.825"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700949"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bmt.1701115","article-title":"Quality of life and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year","volume":"21","author":"McQuellon RP","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050407"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705664"},{"key":"e_1_2_5_25_2","unstructured":"AndersonKG GiraltSA NeumannJL et al.Symptom assessment following autologous transplantation: relation of symptom severity to laboratory measures. American Society of Hematology 45th Annual Meeting San Diego California December 6\u20139 2003."},{"key":"e_1_2_5_26_2","unstructured":"AndersonK.Symptom assessment following autologous transplantation: relation of symptom severity to laboratory measures. American Society of Hematology 45th Annual Meeting San Diego California December 6\u20139 2003."},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705041"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)90129-5"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.569"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2004"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001603957"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3250"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703007"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb01583.x"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc927"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1385\/CRIAI:28:3:177"},{"key":"e_1_2_5_38_2","unstructured":"WangXS GiraltSA WarnekeCL et al.Mixed effects modeling of the relationship of cytokines and symptom severity in patients during the first 30 days of autologous BMT [abstract]. International Society for Quality of Life Research Symposium\u2010Stating the Art: Advancing Outcomes Research Methodology and Clinical Applications. Boston Massachusetts June 27\u201329 2004."},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705138"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.685.bloodjournal862685"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.3.570"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.23299","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.23299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T09:50:23Z","timestamp":1760262623000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.23299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,19]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1002\/cncr.23299"],"URL":"https:\/\/doi.org\/10.1002\/cncr.23299","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,19]]}}}